Alcon Reports First Quarter 2020 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/1/2026
- Wall Street ends higher as Amazon soothes AI jitters
- Amazon shares rally as cloud growth surges and spending outlook climbs
- Apple shares sink on disappointing September quarter sales outlook
- Novo Nordisk stock tumbles 10% as key trial misses goal
- AI wizkid Leopold Aschenbrenner forced to sell entire portfolio after rout
- SCYNEXIS (SCYX) Move Attributed to Morning Note from Brookline
- AbbVie (ABBV) Misses Q2 EPS by 6c, Beats on Revenue; Offers FY26 EPS Guidance
- Short sellers pile into SpaceX ahead of earnings, lockup expiration
- Wall Street ends higher as Amazon soothes AI jitters
- Novo Nordisk's ziltivekimab fails to reduce heart risk in ZEUS trial
- After-Hours Stock Movers: AAPL, AMZN, COIN, RBLX, RDDT, AXTI, FND, WU, GDDY
- After-Hours Stock Movers: META, MSFT, CMG, SBUX, CVNA, LRCX, FTNT, QCOM, TDOC
- After-Hours Stock Movers: F, BE, STX, WDC, KLAC, SWKS, NXPI, CSGP, ENPH
- After-Hours Stock Movers: FFIV, CDNS, APLD, RMBS, ESI, SANM
- After-Hours Stock Movers: INTC, AMD, ARM, MXL, EW, DECK
Alcon (ALC) Tops Q1 EPS by 10c, Revenues Beat
May 12, 2020 4:34 PM EDTAlcon (NYSE: ALC) reported Q1 EPS of $0.45, $0.10 better than the analyst estimate of $0.35. Revenue for the quarter came in at $1.8 billion versus the consensus estimate of $1.71 billion.
Solid first quarter sales of $1.8 billion, an increase of 3%, or 4% constant currencySuccessful launch of PATADAY strengthens Alcon's leadership in the US OTC allergy marketDecline in global demand for surgical procedures will negatively impact second quarter resultsFocus on associate safety, business continuity and financial flexibility"Our first quarter reflects... More
